Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Parry-Billings

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pulmonary Pharmacology & Therapeutics|April 3, 2003
The inhalers of the future? A review of dry powder devices on the market todayIan J Smith, Mark Parry-Billings
Pulmonary Pharmacology & Therapeutics|September 6, 2005
Evidence based guidelines--a step too far?Alyn H Morice, Mark Parry-Billings
Pulmonary Pharmacology & Therapeutics|January 12, 2007
WITHDRAWN: The Inhalers of the Future? A Review of Dry Powder Devices on the Market TodayIan J Smith, Mark Parry-Billings
International Journal of Pharmaceutics|June 8, 2002
Clickhaler dry powder inhaler: focussed in vitro proof of principle evaluation of a new chemical entity for asthmaRoch Thibert, Mark Parry-Billings, Martin Shott
Current Opinion in Investigational Drugs (London, England : 2000)|December 16, 2010
Oligonucleotides: New therapeutic approaches for asthma and chronic obstructive pulmonary diseaseMark Parry-Billings, Nicolay Ferrari, Rosanne Seguin
Pediatric Pulmonology|February 5, 2003
Inspiratory flow rate through a dry powder inhaler (Clickhaler) in children with asthmaMark Parry-Billings, Claire Birrell, Louise Oldham, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|May 15, 2002
Gamma scintigraphic evaluation of a novel budesonide dry powder inhaler using a validated radiolabeling techniqueSimon Warren, Glyn Taylor, Jeffrey Smith, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pulmonary Pharmacology & Therapeutics|April 3, 2003
The inhalers of the future? A review of dry powder devices on the market todayIan J Smith, Mark Parry-Billings
Pulmonary Pharmacology & Therapeutics|September 6, 2005
Evidence based guidelines--a step too far?Alyn H Morice, Mark Parry-Billings
Pulmonary Pharmacology & Therapeutics|January 12, 2007
WITHDRAWN: The Inhalers of the Future? A Review of Dry Powder Devices on the Market TodayIan J Smith, Mark Parry-Billings
International Journal of Pharmaceutics|June 8, 2002
Clickhaler dry powder inhaler: focussed in vitro proof of principle evaluation of a new chemical entity for asthmaRoch Thibert, Mark Parry-Billings, Martin Shott
Current Opinion in Investigational Drugs (London, England : 2000)|December 16, 2010
Oligonucleotides: New therapeutic approaches for asthma and chronic obstructive pulmonary diseaseMark Parry-Billings, Nicolay Ferrari, Rosanne Seguin
Pediatric Pulmonology|February 5, 2003
Inspiratory flow rate through a dry powder inhaler (Clickhaler) in children with asthmaMark Parry-Billings, Claire Birrell, Louise Oldham, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|May 15, 2002
Gamma scintigraphic evaluation of a novel budesonide dry powder inhaler using a validated radiolabeling techniqueSimon Warren, Glyn Taylor, Jeffrey Smith, et al.
Pageof 1